Document text
Principal Investigator: JOHN H WEISS
Organization: UNIVERSITY OF CALIFORNIA-IRVINE
Fiscal Year: 2024
Award: $544,831
Funding agency: National Institute of Neurological Disorders and Stroke
7. Project Summary/Abstract
Therapy for ischemic brain injury is poor in part because of our limited understanding of mechanisms leading
to neuronal loss. While roles of excessive glutamate release and neuronal Ca2+ accumulation have been much
studied, recent evidence implicates critical contributions of another divalent cation, Zn2+. After ischemia or
prolonged seizures, free Zn2+ accumulates in neurons and observations that Zn2+ chelation is protective
implicates a role in neuronal death. Culture studies have revealed that exogenously applied Zn2+ can enter
neurons and accumulate in mitochondria, powerfully disrupting their function. However, little is known about
mechanisms of injury caused by the accumulation of endogenous Zn2+ in native brain tissues.
Using acute hippocampal slices subjected to oxygen glucose deprivation (OGD) to model ischemia, we
recently made the first simultaneous measurements of cytosolic Zn2+ and Ca2+ changes, and found that Zn2+
accumulation is an early event in hippocampal pyramidal neurons that precedes and contributes to a subsequent
sharp and terminal Ca2+ deregulation event, causatively linked to loss of membrane integrity. We have further
found that the acute deleterious effects of Zn2+ seem to result specifically from its uptake into mitochondria via
the mitochondrial Ca2+ uniporter (MCU). In ongoing slice studies, we find evidence for major differences between
sources of the Zn2+ that accumulates in hippocampal CA1 and CA3 pyramidal neurons contributing to acute
OGD induced damage, with considerable Zn2+ accumulation in mitochondria of CA1 but not of CA3 neurons at
delayed time points after a sublethal episode of OGD. These differences in Zn2+ contributions may bear upon
the differential vulnerabilities of CA1 vs CA3 neurons in disease conditions, with CA1 preferentially degenerating
after transient global ischemia, and CA3 after recurrent limbic seizures.
This proposal continues ongoing studies, generally organized around a Hypothesis: Mitochondrial Zn2+
accumulation is an early event after transient ischemia, which causes disruption of mitochondrial function and
contributes to delayed cell death. Aim I applies imaging techniques to acute hippocampal slices to further clarify
mitochondrial effects of Zn2+ in hippocampal neurons in the hours after transient oxygen glucose deprivation (as
a model of ischemia), and to study events occurring after restoration of O2/glucose (“reperfusion”) that may be
amenable to beneficial therapeutic interventions. Aim II seeks to make initial test of principle studies of our
hypothesis in an in vivo rat global ischemia model.
These studies will provide mechanistic insights that will aid the development of new and effective therapeutic
interventions to be delivered after an episode of transient ischemia, that will disrupt the pathological cascade,
enabling improved outcomes.
Terms: <Active Follow-up><Acute><Ammon Horn><Area><Asystole><Autoregulation><Binding><Brain><Brain Ischemia><Brain Nervous System><Cardiac Arrest><Cell Death><Cerebrum><Chelating Agents><Chelators><Common Rat Strains><Complexons><Cornu Ammonis><Cytoplasm><D-Glucose><Development><Dextrose><Disease><Disorder><Divalent Cations><Drug Therapy><Drug usage><Encephalon><Event><Glucose><Glutamates><Goals><Heart Arrest><Hilar><Hippocampus><Homeostasis><Hour><Imaging Procedures><Imaging Technics><Imaging Techniques><In Vitro><Injury><Intervention><Intervention Strategies><Investigators><Ions><Ischemia><Ischemic Brain Injury><Ischemic Encephalopathy><Ischemic Neuronal Injury><L-Glutamate><Link><Measurement><Membrane><Mitochondria><Modeling><Molecular Interaction><Morbidity><Morbidity - disease rate><Motion><N Methyl D aspartic Acid><N methyl D aspartate><N-Methyl-D-aspartate><N-Methylaspartate><NMDA><Nerve Cells><Nerve Degeneration><Nerve Unit><Neural Cell><Neurocyte><Neuron Degeneration><Neuronal Injury><Neurons><O element><O2 element><Oxygen><Pathogenicity><Pathologic><Pharmacotherapy><Physiological Homeostasis><Play><Population><Preparation><Process><Pyramidal neuron><Rat><Rats Mammals><Rattus><Recurrence><Recurrent><Reperfusion Therapy><Research Personnel><Researchers><Role><Seizures><Severities><Site><Slice><Source><Synapses><Synaptic><Testing><Therapeutic Intervention><Time><active followup><aged group><aged groups><aged individual><aged individuals><aged people><aged person><aged persons><aged population><aged populations><aging population><antagonism><antagonist><brain tissue><cerebral><chelation><deprivation><developmental><disability><drug treatment><drug use><excitotoxic><excitotoxicity><follow up><follow-up><followed up><followup><glutamatergic><hippocampal><hippocampal pyramidal neuron><improved><improved outcome><in vivo><in vivo Model><injuries><insight><intervention therapy><interventional strategy><ischemia injury><ischemic brain damage><ischemic injury><loss of function><membrane structure><mitochondrial><mitochondrial dysfunction><mortality><necrocytosis><nerve cell death><nerve cell loss><neural degeneration><neurodegeneration><neurodegenerative><neurological degeneration><neuron cell death><neuron cell loss><neuron death><neuron injury><neuron loss><neuronal><neuronal cell death><neuronal cell loss><neuronal death><neuronal degeneration><neuronal loss><neuroprotection><neuroprotective><new approaches><novel approaches><novel strategies><novel strategy><population aging><postsynaptic><preparations><preservation><protective efficacy><reperfusion><restoration><social role><stroke model><stroke therapy><stroke treatment><synapse><synapse function><synaptic function><therapeutically effective><treating stroke><uptake>